MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Revenue
$321,375K
Net Income
$36,128K
Net Profit Margin
11.24%
EPS
$0.19
Unit: Thousand (K) dollars
Revenue Breakdown
Transferred At Point In Time
Transferred Over Time
Revenue Breakdown
Sterigenics
Nelson Labs
Nordion
Revenue Breakdown
Service
Product
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Total net revenues
321,375
280,045
303,441
311,312
Service
126,840
118,828
121,052
114,337
Product
16,572
14,148
16,469
19,414
Total cost of revenues
143,412
132,976
137,521
133,751
Gross profit
177,963
147,069
165,920
177,561
Selling, general and administrative expenses
68,156
68,211
57,514
63,294
Amortization of intangible assets
3,015
3,031
3,023
3,090
Litigation settlement-Ethylene Oxide Tort Litigation Georgia
-
-
0*
-
Illinois eo litigation settlements
0
0
584*
0
Interest expense, net
-34,405
-34,745
-35,048
-39,147
Gain on refinancing of debt
-936
-
289*
-1,087
Foreign exchange (gain) loss, net
3,746
571
-1,559
1,528
Other income, net
2,854
960
2,016
464
Income before income taxes
78,051
42,613
70,497
72,935
Provision for income taxes
24,408
16,024
35,650
24,535
Net income (gain)
53,643
26,589
34,847
48,400
Pension and post-retirement benefits (net of taxes of (33), 24, (69), and 27, respectively)
98
104
-2,317
12
Interest rate derivatives (net of taxes of 403, (386), 963 and (652), respectively)
1,174
1,633
-164
-29
Foreign currency translation
-18,591
-17,631
13,516
-17,178
Comprehensive income
36,128
10,487
50,516
31,181
Basic EPS
0.19
0.09
0.178
0.17
Diluted EPS
0.19
0.09
0.174
0.17
Basic Average Shares
285,773,000
284,887,000
284,266,000
284,067,000
Diluted Average Shares
288,148,000
287,622,000
289,625,000
286,745,000
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
1
2
3
Sterigenics
$211,571K
(8.59%↑ Y/Y)
Nordion
$47,232K
(14.17%↑ Y/Y)
Nelson Labs
$60,655K
(6.28%↑ Y/Y)
Nordion
$1,917K
(80.85%↑ Y/Y)
Transferred At Point In Time
$258,803K
(9.56%↑ Y/Y)
Transferred Over Time
$62,572K
(7.64%↑ Y/Y)
Total net revenues
$321,375K
(9.18%↑ Y/Y)
Gross profit
$177,963K
(6.81%↑ Y/Y)
Foreign exchange (gain)
loss, net
$3,746K
(697.45%↑ Y/Y)
Total cost of revenues
$143,412K
(12.29%↑ Y/Y)
Other income, net
$2,854K
(-51.00%↓ Y/Y)
Income before income
taxes
$78,051K
(313.03%↑ Y/Y)
Selling, general and
administrative expenses
$68,156K
(-1.07%↓ Y/Y)
Interest expense, net
-$34,405K
(15.36%↑ Y/Y)
Amortization of intangible
assets
$3,015K
(-67.57%↓ Y/Y)
Service
$126,840K
(11.96%↑ Y/Y)
Product
$16,572K
(14.87%↑ Y/Y)
Gain on refinancing
of debt
-$936K
(-1070.00%↓ Y/Y)
Net income (gain)
$53,643K
(573.74%↑ Y/Y)
Interest rate
derivatives (net of taxes of...
$1,174K
(204.54%↑ Y/Y)
Provision for income taxes
$24,408K
(123.21%↑ Y/Y)
Comprehensive income
$36,128K
Foreign currency
translation
-$18,591K
(-122.61%↓ Y/Y)
Pension and
post-retirement benefits (net of...
$98K
(238.03%↑ Y/Y)
Buy us a coffee
2022 Annual Report_Final As Filed-1-pdf-svg
Sotera Health Co (SHC)
2022 Annual Report_Final As Filed-1-pdf-svg
Sotera Health Co (SHC)